Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2015 Jul 3

PMID 26134438

Citations 11

Authors

Chunhao Wang

Janet K Horton

Fang-Fang Yin

Zheng Chang

Affiliations

Soon will be listed here.

Abstract

Single-dose preoperative stereotactic body radiotherapy is a novel radiotherapy technique for the early-stage breast cancer, and the treatment response pattern of this technique needs to be investigated on a quantitative basis. In this work, dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging were used to study the treatment response pattern in a unique cohort of patients with early-stage breast cancer treated with preoperative radiation. Fifteen female qualified patients received single-dose preoperative radiotherapy with 1 of the 3 prescription doses: 15 Gy, 18 Gy, and 21 Gy. Magnetic resonance imaging scans including both diffusion-weighted magnetic resonance imaging and dynamic contrast-enhanced magnetic resonance imaging were acquired before radiotherapy for planning and after radiotherapy but before surgical resection. In diffusion-weighted magnetic resonance imaging, the regional averaged apparent diffusion coefficient was calculated. In dynamic contrast-enhanced magnetic resonance imaging, quantitative parameters K (trans) and v e were evaluated using the standard Tofts model based on the average contrast agent concentration within the region of interest, and the semiquantitative initial area under the concentration curve (iAUC6min) was also recorded. These parameters' relative changes after radiotherapy were calculated for gross tumor volume, clinical target volume, and planning target volume. The initial results showed that after radiotherapy, initial area under the concentration curve significantly increased in planning target volume (P < .006) and clinical target volume (P < .006), and v e significantly increased in planning target volume (P < .05) and clinical target volume (P < .05). Statistical studies suggested that linear correlations between treatment dose and the observed parameter changes exist in most examined tests, and among these tests, the change in gross tumor volume regional averaged apparent diffusion coefficient (P < .012) and between treatment dose and planning target volume K (trans) (P < .029) were found to be statistically significant. Although it is still preliminary, this pilot study may be useful to provide insights for future works.

Citing Articles

A narrative review for radiation oncologists to implement preoperative partial breast irradiation.

Zerella M, Zaffaroni M, Ronci G, Dicuonzo S, Rojas D, Morra A Radiol Med. 2023; 128(12):1553-1570.

PMID: 37650981 DOI: 10.1007/s11547-023-01706-6.

Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature.

Civil Y, Jonker L, Groot Koerkamp M, Duvivier K, de Vries R, Oei A Ann Surg Oncol. 2023; 30(6):3263-3279.

PMID: 36869253 PMC: 10175515. DOI: 10.1245/s10434-023-13233-9.

Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions.

Takanen S, Pinnaro P, Farina I, Sperati F, Botti C, Vici P Front Oncol. 2022; 12:953810.

PMID: 36313648 PMC: 9606691. DOI: 10.3389/fonc.2022.953810.

Dynamic Contrast-enhanced and Diffusion-weighted Magnetic Resonance Imaging for Response Evaluation After Single-Dose Ablative Neoadjuvant Partial Breast Irradiation.

Vasmel J, Groot Koerkamp M, Mandija S, Veldhuis W, Moman M, Froeling M Adv Radiat Oncol. 2022; 7(2):100854.

PMID: 35387418 PMC: 8977856. DOI: 10.1016/j.adro.2021.100854.

Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy.

Wang C, Padgett K, Su M, Mellon E, Maziero D, Chang Z Med Phys. 2021; 49(4):2794-2819.

PMID: 34374098 PMC: 9769892. DOI: 10.1002/mp.15130.

References

Rangarajan A, Chui H, Duncan J . Rigid point feature registration using mutual information. Med Image Anal. 2000; 3(4):425-40. DOI: 10.1016/s1361-8415(99)80034-6. View

Tofts P . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997; 7(1):91-101. DOI: 10.1002/jmri.1880070113. View

Murase K . Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med. 2004; 51(4):858-62. DOI: 10.1002/mrm.20022. View

Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S . Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009; 50(7):1020-7. DOI: 10.2967/jnumed.109.062638. View

Wang C, Yin F, Horton J, Chang Z . Review of treatment assessment using DCE-MRI in breast cancer radiation therapy. World J Methodol. 2014; 4(2):46-58. PMC: 4202481. DOI: 10.5662/wjm.v4.i2.46. View

Vaupel P . Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004; 14(3):198-206. DOI: 10.1016/j.semradonc.2004.04.008. View

Formenti S, Truong M, Goldberg J, Mukhi V, Rosenstein B, Roses D . Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004; 60(2):493-504. DOI: 10.1016/j.ijrobp.2004.04.036. View

OConnor J, Jackson A, Parker G, Roberts C, Jayson G . Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol. 2012; 9(3):167-77. DOI: 10.1038/nrclinonc.2012.2. View

Polgar C, Strnad V, Major T . Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol. 2005; 15(2):116-22. DOI: 10.1016/j.semradonc.2004.10.004. View

10.

Paran Y, Bendel P, Margalit R, Degani H . Water diffusion in the different microenvironments of breast cancer. NMR Biomed. 2004; 17(4):170-80. DOI: 10.1002/nbm.882. View

11.

Treier R, Steingoetter A, Fried M, Schwizer W, Boesiger P . Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med. 2007; 57(3):568-76. DOI: 10.1002/mrm.21177. View

12.

Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H . 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999; 17(8):2326-33. DOI: 10.1200/JCO.1999.17.8.2326. View

13.

Katz A, Carey-Sampson M, Muhs A, Milano M, Schell M, Okunieff P . Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2007; 67(3):793-8. DOI: 10.1016/j.ijrobp.2006.10.025. View

14.

Hylton N . Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006; 24(20):3293-8. DOI: 10.1200/JCO.2006.06.8080. View

15.

Tofts P, Brix G, Buckley D, Evelhoch J, Henderson E, Knopp M . Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999; 10(3):223-32. DOI: 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s. View

16.

Nattinger A, Kneusel R, Hoffmann R, Gilligan M . Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001; 93(17):1344-6. DOI: 10.1093/jnci/93.17.1344. View

17.

Jagsi R, Ben-David M, Moran J, Marsh R, Griffith K, Hayman J . Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2009; 76(1):71-8. PMC: 4414125. DOI: 10.1016/j.ijrobp.2009.01.041. View

18.

Smith D, Li X, Gambrell J, Arlinghaus L, Quarles C, Yankeelov T . Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI. IEEE Trans Med Imaging. 2011; 31(2):504-11. PMC: 3289060. DOI: 10.1109/TMI.2011.2172216. View

19.

Zimmermann F, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U . Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol. 2006; 45(7):796-801. DOI: 10.1080/02841860600913210. View

20.

Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S . Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat. 2004; 83(1):67-76. DOI: 10.1023/B:BREA.0000010700.11092.f4. View